(Q34332052)

1 August 2017

title

Malignancy-related causes of death in human immunodeficiency virus-infected patients in the era of highly active antiretroviral therapy. (English)

1 reference

1 August 2017

main subject

anti-retroviral agent

0 references

0 references

9

Geneviève Chêne

1 reference

1 August 2017

Dominique Costagliola

7

object named as

Dominique Costagliola

0 references

Fabrice Bonnet

1

object named as

Fabrice Bonnet

1 reference

1 August 2017

Charlotte Lewden

2

1 reference

1 August 2017

Thierry May

3

1 reference

1 August 2017

Laurence Heripret

4

1 reference

1 August 2017

Eric Jougla

5

1 reference

1 August 2017

Sibylle Bevilacqua

6

1 reference

1 August 2017

Dominique Salmon

8

1 reference

1 August 2017

Philippe Morlat

10

1 reference

1 August 2017

language of work or name

English

0 references

publication date

1 July 2004

1 reference

1 August 2017

number of pages

8

1 reference

inferred from page(s)

published in

Cancer

1 reference

1 August 2017

volume

101

1 reference

1 August 2017

issue

2

1 reference

1 August 2017

page(s)

317-324

1 reference

AIDS across Europe, 1994-98: the EuroSIDA study

1 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20354

Causes of death among HIV-infected patients in the era of highly active antiretroviral therapy, Bordeaux, France, 1998-1999.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20354

Causes of death among women with human immunodeficiency virus infection in the era of combination antiretroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20354

Causes of death in persons with human immunodeficiency virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20354

Mortality due to hepatitis C-related liver disease in HIV-infected patients in France (Mortavic 2001 study).

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20354

Changes in AIDS-related lymphoma since the era of highly active antiretroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20354

B-cell stimulation and prolonged immune deficiency are risk factors for non-Hodgkin's lymphoma in people with AIDS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20354

Improved survival in HIV-related Hodgkin's lymphoma since the introduction of highly active antiretroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20354

Highly active antiretroviral therapy and incidence of cancer in human immunodeficiency virus-infected adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20354

Lung carcinoma in 36 patients with human immunodeficiency virus infection. The Italian Cooperative Group on AIDS and Tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20354

Incidence of non-AIDS-defining cancers before and during the highly active antiretroviral therapy era in a cohort of human immunodeficiency virus-infected patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20354

Association of Cancer With AIDS-Related Immunosuppression in Adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20354

Spectrum of AIDS-associated malignant disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20354

Risk of cancer in people with AIDS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20354

Changes in the cause of death among HIV positive subjects across Europe: results from the EuroSIDA study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20354

Trends in causes of death in the Aquitaine cohort of HIV-infected patients, 1995-1997

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20354

7 January 2021

Decreasing rates of Kaposi's sarcoma and non-Hodgkin's lymphoma in the era of potent combination anti-retroviral therapy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20354

7 January 2021

Systemic non-Hodgkin lymphoma in HIV-infected patients with effective suppression of HIV replication: persistent occurrence but improved survival

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20354

7 January 2021

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20354

7 January 2021

Pre-AIDS mortality in HIV-infected individuals in England, Wales and Northern Ireland, 1982-1996.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20354

7 January 2021

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20354

7 January 2021

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20354

7 January 2021

An RGD containing peptide from HIV-1 Tat-(65-80) modulates protooncogene expression in human bronchoalveolar carcinoma cell line, A549.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20354

7 January 2021

Identifiers

DOI

10.1002/CNCR.20354

1 reference

1 August 2017

1 reference